ZyCov-D: PM Modi lauds Indian scientists as world’s first DNA Covid-19 vaccine gets CDSCO approval

The approval for world’s first DNA based ‘ZyCov-D’ vaccine of @ZydusUniverse is a testimony to the innovative zeal of India’s scientists, says Prime Minister Narendra Modi.


Prime Minister Narendra Modi (PHPTO: PIB)

In yet another breakthrough in the development of COVID-19 vaccine, CDSCO has approved DNA COVID-19 vaccine (ZyCoV-D) of Cadila Healthcare for restricted use in emergency situation in India for 12 years and above. Lauding Indian scientists, Prime Minister Narendra Modi on Saturday said the approval for world’s first DNA based ‘ZyCov-D’ vaccine of Zydus Universe is a testimony to the innovative zeal of India’s scientists. 

In response to a tweet by CDSCO India Info, Modi said in a Twitter post that the development of DNA based ZyCov-D vaccine is a momentous feat.

 

"India is fighting COVID-19 with full vigour. The approval for world’s first DNA based ‘ZyCov-D’ vaccine of @ZydusUniverse is a testimony to the innovative zeal of India’s scientists. A momentous feat indeed," PM Tweeted.

CDSCO - Central Drugs Standard Control Organisation under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, is India's National Regulatory Authority.

"After evaluation of interim Phase III clinical trial results in consultation with Subject Expert Committee, CDSCO has approved DNA COVID-19 vaccine (ZyCoV-D) of M/s Cadila Healthcare for restricted use in emergency situation in India for 12 years and above," CDSCO said in a series of tweets.

The vaccine has efficacy of 66.6 per cent, CDSCO India Info said.

"The vaccine has efficacy of 66.6% and it is to be stored at 2°C to 8°C. The vaccine is needle free to be administered intradermally in three doses at day 0, 28 and 56," CDSCO tweeted.

First Published:Aug. 21, 2021, 10:05 a.m.

Leave a comment